TY  - JOUR

T1  - Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.

JO  - Platelets

PY  - 2009/08/01

AU  - Storey RF

AU  - Melissa Thornton S

AU  - Lawrance R

AU  - Husted S

AU  - Wickens M

AU  - Emanuelsson H

AU  - Cannon CP

AU  - Heptinstall S

AU  - Armstrong M

ED  - 

DO  - DOI: 10.1080/09537100903075324

VL  - 20

IS  - 5

SP  - 341

EP  - 348

Y2  - 2024/12/28

ER  -